John Murray, MD
Dermatology · Durham, NCNPI 1043256258
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.7%), education and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Arcutis Biotherapeutics, Inc. at 57.7% of the total. Reporting peaked in 2023 at $966 and has fallen 76.5% since, to $227 in 2024. That places this record below the midpoint for dermatology clinicians in NC, where the typical reported total is $2,057.
Across 8 payments — averaging $162.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$750
- Johnson & Johnson$385
- AbbVie$121
- Boston Scientific$29
- Sun Pharmaceutical Industries Inc.$16
Across 29 payments — averaging $4142.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$48K
- AbbVie$33K
- E.r. Squibb & Sons, L.L.C.$22K
- Boehringer Ingelheim$16K
- Boehringer Ingelheim Pharma GmbH & Co.kg$1K
What the payments were for
- Consulting fees$75058%
- Food & beverage$16513%
- Education$38530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 1 | $750 |
| Johnson & Johnson | 4 | $385 |
| AbbVie | 1 | $121 |
| Boston Scientific | 1 | $29 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$121
How this compares
$1,300 in reported general payments places this provider in the 35th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 36 | $766,590 |
| Humira(Cf) PenAdalimumab | 72 | $667,214 |
| Enbrel SureclickEtanercept | 11 | $161,325 |
| OtezlaApremilast | 24 | $153,520 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $118,616 |
| Dupixent SyringeDupilumab | 22 | $82,735 |
| Dupixent PenDupilumab | 15 | $50,749 |
| ZoryveRoflumilast | 18 | $15,071 |
| Tacrolimus | 59 | $6,986 |
| Clobetasol Propionate | 144 | $6,258 |
| Calcipotriene | 42 | $6,076 |
| Acitretin | 20 | $5,254 |
| Fluorouracil | 49 | $3,736 |
| Fluocinonide | 52 | $3,354 |
| Tretinoin | 26 | $2,759 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Arcutis Biotherapeutics, Inc.Zoryve | $750 | $15,07118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 475 dermatology providers in North Carolina.
Other dermatology in Durham
- Jeffrey ScalesDurham$279K
- Negar FooladDurham$76K
- Russell HallDurham$65K
- Elise OlsenDurham$64K
- Brooke JacksonDurham$38K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.